send to a friend by email
2023-05-16
According to the financial statements of Birzeit Pharmaceuticals for the 1st Quarter of 2023, Net profit after tax of the period reached 1,794,391 USD Compared with Net profit after tax 3,074,920 USD for 2022, a net decrease in profit of 41.64%.Total assets of the company reached 126,676,896 USD compared with total assets of 123,003,262 USD at the end of year 2022, a net increase of 2.99%.Total liabilities of the company reached 20,029,282 USD compared with total liabilities of 19,489,454 USD at the end of year 2022, a net increase of 2.76%. Net ownership equity of the company reached 106,647,614 USD (Including Non-Controlling Interests of 942,938 USD) compared with total owner equity of 103,513,808 USD (Including Non-Controlling Interests of 923,623 USD) at the end of year 2022, a net increase of 3.03%.
|
|